Dowd Scheffel Co-Authors Amicus Brief Supporting En Banc Review in Design Patent Case
Dowd Scheffel co-authored an amicus brief urging the full Federal Circuit to reassess the standard for design-patent infringement. The case at issue is Range and Motions Products, LLC v. Armaid Co. Inc. Dowd Scheffel founder Matthew J. Dowd, along with Robert J. Scheffel and Elliot Gee, drafted the amicus brief with amicus curiae Perry J. Saidman. The amicus brief urges the appeals court to reconsider the increasingly applied "plainly dissimilar" doctrine in design patent
May 1
Matthew Dowd Participates in USPTO PTAB Listening Session on Life Sciences
Matthew Dowd recently participated as a panelist in the USPTO’s PTAB Listening Session: PTAB and Life Sciences. The panel was held on March 30, 2026, at the USPTO headquarters in Alexandria, Virginia. The program was the first in the USPTO’s 2026 three-part spring listening series addressing key topics related to the PTAB and other top-priority patent issues. The session brought together USPTO officials and experienced practitioners to discuss current issues and stakeholder
Apr 1
Dowd Scheffel Files Amicus Brief Urging Supreme Court to Reinforce AIA’s Limits
Dowd Scheffel, in collaboration with Caldwell Cassady & Curry PC, filed an amicus brief on behalf of former Congressman Lamar Smith, former USPTO Director David Kappos, former Chief Judge Paul Michel, and IP leader Philip Johnson in Lynk Labs Inc. v. Samsung Electronics Co., Ltd . The brief argues that the Federal Circuit’s decision allowing unpublished patent application as prior art in IPRs conflicts with the AIA. Congress intended IPRs to be limited to “patents and printed
Dec 8, 2025
Matthew J. Dowd and Hon. Paul R. Michel (Ret.) Discuss Biotech Patent Eligibility
In a recent IPWatchdog article, Judge Paul R. Michel (Ret.) and Matthew J. Dowd revisit the landmark Diamond v. Chakrabarty decision and its relevance to today’s biotech innovations. The article analyzes the Federal Circuit appeal in Regenxbio v. Sarepta, where the court must decide whether a man-made host cell qualifies as patent eligible under Section 101. Drawing on precedent from Chakrabarty and Myriad , Dowd and Judge Michel emphasize why maintaining strong patent prote
Nov 19, 2025
USPTO Cites Michel & Dowd Article in Proposed Rulemaking on PTAB Changes
In October 2025, the USPTO issued a notice of proposed rulemaking (“NPRM”) to revise procedures for IPRs before the PTAB. In the NPRM, the USPTO cited and quoted the article Patent Protection: A Crucial Antitrust Tool for Increasing Innovation , authored by the Honorable Paul R. Michel (ret.) and Dowd Scheffel partner Matthew J. Dowd . The USPTO referenced the article to underscore the importance of reliable patent rights in fostering innovation and economic growth, partic
Oct 21, 2025
Dowd Scheffel Files Amicus Brief for Former Fed Cir Judges and Others
On July 18, 2025, Dowd Scheffel PLLC filed an amicus curiae brief on behalf of a distinguished group of former federal judges, a former...
Jul 21, 2025
Dowd Scheffel PLLC Urges Court to Reconsider Key Design-Patent Infringement Test
Dowd Scheffel PLLC, on behalf of client North Star Technology International Ltd., filed a petition for en banc rehearing at the U.S....
Jun 30, 2025
